Full video transcriptClick to expand
Auto-generated transcript of @ann_havenly's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Here's what I eat in the day as a 37 year old and yes, I'm my good host on GLP one.
- 0:04I start my day off with a hot cup of black coffee.
- 0:06I'm going for a workout this morning so I add protein collagen, creatine in it along
- 0:11with some avocado, spinach and banana.
- 0:13And a touch of olive oil.
- 0:15For lunch I had this fresh Mahi barbecue salad with some spearmint tea.
- 0:20I asked it for dinner.
- 0:21I had ransino and me and my friend shared this moles free and yes I ate all of those
- 0:27fries.
- 0:28They were so delicious.
GLP-1 'what I eat in a day' videos: separating real from reel
Quick answer
Ann is using a GLP-1 receptor agonist for weight management and describes a day of eating that is protein-forward in the morning, lean at lunch, and flexible at dinner including fried foods. Her morning beverage is functionally a blended meal containing fat, fiber, protein, and carbohydrates, which may interact with the already-slowed gastric emptying that GLP-1 medications produce. No specific drug, dose, or brand is mentioned, and no therapeutic claims are made.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For GLP-1 'what I eat in a day' videos: separating real from reel, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of RCTs
Pooled 23 RCTs; the apparent benefit on skin hydration and elasticity disappeared in high-quality and non-industry-funded trials, so the authors found no reliable evidence of benefit.
PubMed
Oral Low-Molecular-Weight Collagen Peptide Improves Hydration, Elasticity, and Wrinkling: A Randomized Double-Blind Placebo-Controlled Study
64-participant 12-week RCT reporting improved skin hydration and wrinkle measures; an industry-affiliated trial, so the modest effects should be read in that context.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
GLP-1 'what I eat in a day' videos: separating real from reel should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "GLP-1 'what I eat in a day' videos: separating real from reel" from Ann Havenly. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Ann is using a GLP-1 receptor agonist for weight management and describes a day of eating that is protein-forward in the morning, lean at lunch, and flexible at dinner including fried foods.
The reason this review is not generic is the source wording and the canonical claim label "glp1 what i eat in a day whatieat health fitness pilates food." In this clip, the useful excerpt is: "Here's what I eat in the day as a 37 year old and yes, I'm my good host on GLP one." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), Discontinuing glucagon-like peptide-1 receptor agonists and body habitus (2025), and Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition (2025), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Ann is using a GLP-1 receptor agonist for weight management and describes a day of eating that is protein-forward in the morning, lean at lunch, and flexible at dinner including fried foods.
FormBlends verdict
GLP-1 social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Ann is using a GLP-1 receptor agonist for weight management and describes a day of eating that is protein-forward in the morning, lean at lunch, and flexible at dinner including fried foods. Her morning beverage is functionally a blended meal containing fat, fiber, protein, and carbohydrates, which may interact with the already-slowed gastric emptying that GLP-1 medications produce. No specific drug, dose, or brand is mentioned, and no therapeutic claims are made.
- Protein intake actively supports GLP-1 therapy: dietary protein stimulates endogenous GLP-1 secretion, adding to the medication's appetite suppression (Lejeune et al., 2006, American Journal of Clinical Nutrition).
- GLP-1 medications slow gastric emptying significantly, so adding a high-fat, high-fiber morning blend on top may intensify GI symptoms like nausea or bloating in some users.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Protein intake actively supports GLP-1 therapy: dietary protein stimulates endogenous GLP-1 secretion, adding to the medication's appetite suppression (Lejeune et al., 2006, American Journal of Clinical Nutrition).
- GLP-1 medications slow gastric emptying significantly, so adding a high-fat, high-fiber morning blend on top may intensify GI symptoms like nausea or bloating in some users.
- The STEP 1 trial (Wilding et al., 2021, NEJM) did not require clean eating to achieve 14.9% average body weight reduction, meaning fries at dinner do not undermine GLP-1 outcomes.
- Muscle loss is a real concern on GLP-1 therapy: Lim et al. (2021, Obesity Reviews) found lean mass loss accompanies fat loss without resistance training and adequate protein intake.
- Creatine monohydrate has no known interaction with GLP-1 receptor agonists and has strong evidence for supporting strength performance (Lanhers et al., 2017, European Journal of Sport Science).
- Collagen peptides are an incomplete protein source and should not be the primary protein supplement; pairing with a complete protein, as shown in this video, is the appropriate approach.
- A 'what I eat in a day' video from one person on one medication dose is not a dietary template. Individual GLP-1 dosing, tolerability, and metabolic response vary substantially between patients.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @ann_havenly actually say?
Ann is a 37-year-old on a GLP-1 medication and shared a full day of eating. Her morning routine is the most medically interesting part: black coffee blended with protein powder, collagen, creatine, avocado, spinach, banana, and olive oil. For lunch she had a Mahi barbecue salad with spearmint tea. Dinner was at a restaurant, where she shared a meal with a friend and ate fries, which she made a point of mentioning: "I ate all of those fries. They were so delicious."
There are no explicit health claims here beyond the implicit message that this is a reasonable, balanced way to eat while on a GLP-1. That framing is worth examining because 204,000 people are watching and drawing conclusions from it.
Does the science back this up?
Mostly, yes, with some important nuance around the morning coffee concoction and what it actually does to appetite and GLP-1 efficacy.
The protein-forward morning makes sense. GLP-1 receptor agonists like semaglutide already slow gastric emptying and suppress appetite, but dietary protein further stimulates endogenous GLP-1 release (Lejeune et al., 2006, American Journal of Clinical Nutrition). Stacking protein intake on top of a medication that mimics GLP-1 is not redundant, it is additive in terms of satiety signaling.
Creatine in the morning pre-workout is well-supported. A 2017 meta-analysis (Lanhers et al., European Journal of Sport Science) confirmed creatine monohydrate improves strength performance. There is no known negative interaction between creatine and GLP-1 medications.
Collagen peptides are a weaker protein source, incomplete in amino acid profile, but adding them alongside a more complete protein source is not harmful. The olive oil adds monounsaturated fat, which slows digestion further, relevant when GLP-1 already slows gastric emptying significantly.
What did they get wrong (or right)?
The biggest thing she got right is something she probably did not intend as a statement: she ate fries and moved on. That is actually clinically appropriate messaging for people on GLP-1s. A persistent myth in GLP-1 communities is that the medication only works if you eat perfectly clean. That is not what the trials show. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) tested semaglutide alongside lifestyle counseling, not a rigid elimination diet. The weight loss outcomes were driven by caloric reduction via appetite suppression, not food purity.
What she may have gotten slightly wrong is the sheer volume of fat and fiber going into that morning coffee. Avocado, banana, olive oil, and spinach blended together is a substantial meal, not a coffee additive. That is fine nutritionally, but calling it a "cup of black coffee" undersells what it actually is calorically, which could mislead viewers trying to replicate it on a reduced appetite.
Spearmint tea at lunch is a quiet win. Small trials suggest spearmint has mild anti-androgen properties (Grant, 2010, Phytotherapy Research), potentially relevant for women managing hormonal symptoms alongside GLP-1 therapy, though this is far from settled science.
What should you actually know?
If you are on a GLP-1 and watching this video for guidance, a few things matter more than the specific foods shown.
- Protein is the nutrient to protect on GLP-1 therapy. Reduced appetite often means reduced total intake, and muscle loss is a documented concern. Lim et al. (2021, Obesity Reviews) found that GLP-1-driven weight loss includes a meaningful lean mass component without resistance training and adequate protein.
- That morning blend is nutritionally dense and calorie-rich. If your GLP-1 is suppressing appetite and you are adding avocado, banana, and olive oil to your coffee, account for it. Do not assume it is a "freebie" because it is liquid.
- The fries-at-dinner behavior is not a failure of the diet. Rigid restriction on top of medication-induced appetite suppression is associated with disordered eating patterns in some patients. Flexibility matters.
- Creatine use while on GLP-1 is reasonable for people doing resistance training. There is no contraindication, and preserving muscle during weight loss is a legitimate goal.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Ann Havenly · TikTok creator
204.7K views on this video
what I eat in a day 🌸 #whatieat #health #fitness #pilates #food
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about protein intake actively supports glp-1 therapy: dietary protein stimulates endogenous?
Protein intake actively supports GLP-1 therapy: dietary protein stimulates endogenous GLP-1 secretion, adding to the medication's appetite suppression (Lejeune et al., 2006, American Journal of Clinical Nutrition).
What does the video say about glp-1 medications slow gastric emptying significantly, so adding a high-fat,?
GLP-1 medications slow gastric emptying significantly, so adding a high-fat, high-fiber morning blend on top may intensify GI symptoms like nausea or bloating in some users.
What does the video say about the step 1 trial (wilding et al., 2021, nejm) did?
The STEP 1 trial (Wilding et al., 2021, NEJM) did not require clean eating to achieve 14.9% average body weight reduction, meaning fries at dinner do not undermine GLP-1 outcomes.
What does the video say about muscle loss?
Muscle loss is a real concern on GLP-1 therapy: Lim et al. (2021, Obesity Reviews) found lean mass loss accompanies fat loss without resistance training and adequate protein intake.
What does the video say about creatine monohydrate has no known interaction with glp-1 receptor agonists?
Creatine monohydrate has no known interaction with GLP-1 receptor agonists and has strong evidence for supporting strength performance (Lanhers et al., 2017, European Journal of Sport Science).
What does the video say about collagen peptides?
Collagen peptides are an incomplete protein source and should not be the primary protein supplement; pairing with a complete protein, as shown in this video, is the appropriate approach.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Ann Havenly, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.